Clinical trial
A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia
NCT01678924 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia
- Lead sponsor
- Allergan
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- January 31, 2013
- Completion date
- September 30, 2015
- Enrollment
- 280 (actual)
- Sites
- 69
Conditions
As the registry lists them; a condition with its own page is linked.